Imagin Medical Inc is a Canada-based medical imaging company. The Company is engaged in the development of i/Blue imaging system for the early detection of cancer through the use of endoscopes. The Company focuses on managing the way physicians detect cancer. The Company's initial target market is bladder cancer. The Company's imaging technology is based upon optical designs and advanced light sensors. The Company develops Prototype Alpha B, a combination of optical/light sensor technology, white light and near-infrared fluorescence that is estimated to be more sensitive than current systems with the ability to expose the specifics of the image. The i/Blueâ€™s cameras employ Simultaneous Acquisition of Differing Images, a patented technology, which blends the white and blue light images into one, putting cancer into context and enabling surgeons to visualize and resect cancer.